The present invention is a device for transcutaneous application of CO.sub.2, which comprises: a therapeutic chamber comprising at least a portion to receive a part of a patient's body to which the carbon dioxide is to be applied, an inlet/outlet pipe connecting the chamber with a CO.sub.2 distribution system, the said pipe connecting the chamber with a CO.sub.2 distribution system, wherein a gate valve for sealing the chamber is installed in the chamber where the inlet/outlet pipe is installed; the CO.sub.2 distribution system comprising a housing where at least the following components are installed: a first pipe with a first valve for suction of air out of the chamber, a second pipe with a second valve for supplying CO.sub.2 from a tank; wherein the first and second pipe are combined into the inlet/outlet pipe upstream of the valves; at least one ventilator for ensuring air flow through the said valves and inlet/outlet pipe, an outlet pipe for leading the used air from the chamber through the wall to the external environment of the building where the device is installed; and at least one tank for storing CO.sub.2 suitably connected to the second pipe.

The apparatus according to the invention is adapted for transcutaneous treatment by gas. The apparatus (10) comprises a rigid-wall cabinet (20) and having an upper opening and at least one openable panel, wherein a seat (25) is arranged inside the cabinet (20), and the cabinet (20) comprises at least one gas concentration measurement unit (29a), and the cabinet (20) further comprises a gas inlet (30) for feeding the treatment gas and a gas outlet (31) for discharging the treatment gas; a gas supply unit (40) coupled to the gas inlet (30) of the cabinet (20) via a pipe (41) and through an interposed controllable valve (42); and a gas tank (50) connected to the gas supply unit (40). The apparatus further comprises a ventilation unit (60) connected to the gas outlet (31) of the cabinet (20) through an interposed controllable valve (63), said ventilation unit (60) being coupled via a further pipe (62) to a space (70) hermetically separated from the room containing the cabinet (20), and wherein said ventilation unit (60) is designed so that it can discharge the entire volume of the treatment gas from the inner space of the cabinet (20) within at most 5 seconds. The apparatus further comprises a control unit (80) for receiving the signals of the gas concentration measurement unit (29a) and for controlling operation of the valves (42, 63) and said ventilation unit (60) based on at least the signals of the gas concentration measurement unit (29a).

A handheld therapeutic apparatus and method of treatment are disclosed. In one example, the apparatus includes a valve system, a detachable gas cartridge housing unit that houses a gas cartridge or gas delivery from an outside gas cylinder in fluid communication with said valve system, a detachable treatment receptacle for the delivery of gas therapies is in fluid communication with said valve system, and a detachable nozzle in fluid communication with said valve system.

An apparatus to maintain an environment over an anterior surface of a patient eye can include an enclosure sized and shaped to be seated about the patient eye to form a cavity within the enclosure. The enclosure can be configured to contain a fluid other than ambient air in contact with the patient eye. The apparatus can include a fluid regulator in communication with the enclosure, where the fluid regulator can be configured to regulate the composition of the fluid contained within the enclosure.

An apparatus (100) to maintain an environment over an anterior surface of a patient eye can include an enclosure (110) sized and shaped to be seated about the patient eye to form a cavity (112) within the enclosure. The enclosure can be configured to contain a fluid other than ambient air in contact with the patient eye. The apparatus can include a fluid regulator (1209) in communication with the enclosure, where the fluid regulator can be configured to regulate the composition of the fluid contained within the enclosure.

An NO-accumulation apparatus, method and use, comprising: a container (120) defining a cavity for accommodating a liquid (105), an inlet (150) for feeding the liquid into the container (120) and an outlet (151) for delivering the liquid from the container (120) to a bath unit; an NO-gas dissolving unit (140) for dissolving gaseous NO in the liquid (105) to produce an NO-containing liquid, wherein the NO-gas dissolving unit (140) is arranged in the container (120) and/or forms a part of the container (120); and an NO-gas port (110) in fluid communication with the NO-gas dissolving unit (140), wherein the NO-gas port (110) is adapted for coupling, particularly for releasably coupling, with an NO-gas supply, whereby the apparatus further comprises means for decoupling the inflow of NO to the liquid (105) within the container from the removal of the NO-containing liquid (NO-decoupling means), so that the removal of the NO-containing liquid is inhibited, when the NO is flowing into the liquid, and also the NO inflow is inhibited when the NO-containing liquid is removed from the container (105).

An apparatus (100) to maintain an environment over an anterior surface of a patient eye can include an enclosure (110) sized and shaped to be seated about the patient eye to form a cavity (112) within the enclosure. The enclosure can be configured to contain a fluid other than ambient air in contact with the patient eye. The apparatus can include a fluid regulator (1209) in communication with the enclosure, where the fluid regulator can be configured to regulate the composition of the fluid contained within the enclosure.

The invention relates to a monitoring and/or respiratory assistance apparatus that can be used during a cardiopulmonary resuscitation (CPR) with successive chest compressions of duration (dt) performed on the patient and with relaxations, said apparatus comprising a CO.sub.2 content measurement sensor (10) a graphical user interface (14), and signal-processing system (11) configured to process the CO.sub.2 content measurement signals in such a way as to determine at least one maximum CO.sub.2 content value (Vmax) and at least one minimum CO.sub.2 content value (Vmin), during at least one duration (dt) of at least one chest contraction, and then to calculate at least one airway opening index AOI or mean index AOI.sub.meanon the basis of the CO.sub.2 content values. Said one or more indices are displayed on the GUI in the form of numerical values or graphical representations, especially curves or pictograms.

The present invention includes an apparatus for transdermal treatments comprising: an openable enclosure for a subject in communication with three or more sources of treatment modalities selected from: a source of ozone; a source of steam, a source of CO.sub.2/Carbonic Acid; a source of Far Infrared; and a source of pulsed electromagnetic fields (PEMF), wherein each of the three or more sources is in communication with an interior of the openable enclosure to treat the subject transdermally.

A bubble-generating apparatus comprises: a casing defining a casing bore extending longitudinally therethrough; and a diffuser located in the casing bore, the diffuser defining a diffuser bore extending longitudinally therethrough. The diffuser bore comprises a fluid-input region at or near a fluid-input end of the diffuser and a fluid-output region at or near a fluid-output end of the diffuser. A cross-sectional area of the diffuser bore in the fluid-input region is greater than the cross-sectional area of the diffuser bore in the fluid-output region. At least a portion of the diffuser is porous for permitting a flow of pressurized gas from a region of the casing bore located outside of the diffuser bore, through the porous portion of the diffuser and into the diffuser bore.